Daiichi/Sankyo Merger Leaves Future Of OTC Unit Up In The Air
This article was originally published in The Tan Sheet
Executive Summary
Daiichi's planned merger with Sankyo may lead to a divestiture of the former's OTC drug businessYou may also be interested in...
Shaklee divested
People In Brief
In Brief
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: